get the top three things to know in women's health + wellness, every weekday:

Preliminary Results Are Good for Non-Surgical Endometriosis Test

What: Hera Biotech company said they got good interim results from clinical trials of their endometriosis diagnostic tool. In the first 38 patients tested, the diagnostic test, which looks at swabbed endometrial cells, has an accuracy rate of 94%.

Why it matters: More data is needed, but Hera CEO said the result “suggests that Hera’s molecular diagnostic test has the potential to replace surgical diagnosis and greatly improve the woefully inadequate state of endometriosis diagnosis and treatment that exists today.”

SourceHera Biotech via BusinessWire

More News Snippets
What to Expect When You’re (Over 40)

I think that most women remember, and may even still have that book on their shelves, What to Expect When You’re Expecting. …Well, there’s no equivalent of that for women over 40. I wrote this book saying to myself, how about what to expect when you expect to live past 40?

TikTok to Start Restricting Weight Loss Content

TikTok is cracking down on creators who focus on weight loss, restricting content about “restrictive diets, ‘using medication or supplements for weight loss or muscle gain,’ or promoting weight loss products” to users who are 18 and up.

Ten Years on the Fertility Cycle

Writer Lisa McCarty tells her arduous, ten-year journey to having two children. It included four embryo transfers and four miscarriages.